Scott L. Friedman, MD, Named Fellow of the American Association for the Advancement of Science

 – December 8, 2014 /Press Release/  –– 

Scott L. Friedman, MD, the Irene and Dr. Arthur M. Fishberg Professor of Medicine, Liver Diseases, and Pharmacology and Systems Therapeutics and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai, has been named as a Fellow of the American Association for the Advancement of Science (AAAS). The election is an honor bestowed on AAAS members by their peers.

Dr. Friedman, a hepatologist and Chief of the Division of Liver Diseases at the Samuel Bronfman Department of Medicine at the Mount Sinai Health System, was recognized for his distinguished contributions to society’s understanding of fibrosis, the process that re-builds connective (scar) tissue as part of healing, but that interferes with the function of organs, including the liver, when it goes too far as part of disease.

“Scott’s many contributions to the study of liver disease, and his shepherding of medical innovations as our Dean for Therapeutic Discovery, make him the ideal AAAS Fellow, and we congratulate Dr. Friedman on this well-deserved honor,” said Dennis Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System.  

Dr. Friedman has performed pioneering research into the underlying causes of scarring, or fibrosis, associated with chronic liver disease, which affects millions worldwide. He was the first to isolate and characterize the hepatic stellate cell, which is the key cell type responsible for scar production in liver. His work has been continuously funded by the NIH since 1985, in addition to grants from American Heart Association, the American Gastroenterological Association and research contracts with a number of companies developing new therapies for liver disease.

401 AAAS members were awarded this honor in 2014 because of their distinguished efforts to advance science or its applications. New Fellows will be presented with an official certificate and rosette pin at a ceremony on February 14 at the AAAS Fellows Forum during the 2015 AAAS Annual Meeting in San Jose, Calif.  This year’s AAAS Fellows were formally announced in the AAAS News & Notes section of the journal Science on November 28.

About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit, or find Mount Sinai on Facebook, Twitter and YouTube.

About AAAS
The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journal Science. AAAS was founded in 1848, and includes some 262 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of one million. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy; international programs; science education; and more.

# # #